In the last trading session, 2.83 million Transmedics Group Inc (NASDAQ:TMDX) shares changed hands as the company’s beta touched 2.11. With the company’s per share price at $62.54 changed hands at -$1.51 or -2.36% during last session, the market valuation stood at $2.10B. TMDX’s last price was a discount, traded about -183.61% off its 52-week high of $177.37. The share price had its 52-week low at $58.27, which suggests the last value was 6.83% up since then. When we look at Transmedics Group Inc’s average trading volume, we note the 10-day average is 3.56 million shares, with the 3-month average coming to 2.16 million.
Analysts gave the Transmedics Group Inc (TMDX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.70. If we narrow down to specifics, the data shows that 0 out of 7 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended TMDX as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight. Transmedics Group Inc’s EPS for the current quarter is expected to be 0.15.
Transmedics Group Inc (NASDAQ:TMDX) trade information
Instantly TMDX was in red as seen at the end of in last trading. With action -17.31%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 0.30%, with the 5-day performance at -17.31% in the red. However, in the 30-day time frame, Transmedics Group Inc (NASDAQ:TMDX) is -7.16% down. Looking at the short shares, we see there were 9.15 million shares sold at short interest cover period of 5.42 days.
The consensus price target for the stock as assigned by Wall Street analysts is 114.5, meaning bulls need an upside of 45.38% from its current market value. According to analyst projections, TMDX’s forecast low is 90 with 145 as the target high. To hit the forecast high, the stock’s price needs a -131.85% plunge from its current level, while the stock would need to soar -43.91% for it to hit the projected low.
Transmedics Group Inc (TMDX) estimates and forecasts
Data shows that the Transmedics Group Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -56.67% over the past 6 months, a 229.87% in annual growth rate that is considerably higher than the industry average of 14.90%. Year-over-year growth is forecast to reach 77.76% up from the last financial year.
Consensus estimates given by 8 financial analysts project the company’s revenue in the current quarter to hit an average of 109.49M. 6 analysts are of the opinion that Transmedics Group Inc’s revenue for the current quarter will be 119.4M. The company’s revenue for the corresponding quarters a year ago was 81.17M and 96.85M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 34.89%. The estimates for the next quarter sales put growth at 23.28%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 8.36%. The 2025 estimates are for Transmedics Group Inc earnings to increase by 227.30%.
TMDX Dividends
Transmedics Group Inc is expected to release its next quarterly earnings report in February.
Transmedics Group Inc (NASDAQ:TMDX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.21% of Transmedics Group Inc shares while 113.47% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 117.24%. There are 113.47% institutions holding the Transmedics Group Inc stock share, with FMR LLC the top institutional holder. As of 2024-06-30, the company held 13.7063% of the shares, roughly 4.49 million TMDX shares worth $676.31 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 8.0755% or 2.65 million shares worth $398.47 million as of 2024-06-30.
Among Mutual Funds, the top two as of Oct 31, 2024 were iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund . With 2.12 shares estimated at $132.9 million under it, the former controlled 6.33% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 3.04% of the shares, roughly 1.02 shares worth around $63.76 million.
